HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With More Consumers Shopping Online During COVID-19, How Do Marketers Keep Them There?

Executive Summary

Convenience and reliability of ordering on Amazon has “shaped our thinking around e-commerce,” says Wayfair product development head Matt Phillips. But marketers walk a fine line between personalization and “creepiness” to keep shoppers coming back for more.

You may also be interested in...



'Tectonic' Shifts In Germany’s OTC Market Require Smart Sales Strategies

Data from Sempora Consulting shows Germany's OTC market is still struggling to return to pre-pandemic growth levels in the first quarter of 2022. Digging deeper into recent trends like e-commerce and inflationary pricing, the firm suggests a number of points for consumer healthcare companies to consider in formulating their sales strategies for the rest of the year.

Transparency Drives Novi's Online Connections For Cosmetic, Dietary Ingredient Buyers And Sellers

Start-up provides platform for suppliers' information about sustainability and other business practices and transparency about ingredients, packaging and other materials. “When you think about ingestibles and vitamins, a lot of companies are starting lines that are in skincare and cosmetics," says CEO Kimberly Shenk.

Naturopath, Regulatory Expert MacKay Returns To DC As CHPA’s Supplement Industry Strategy Chief

Consumer Healthcare Products Association names Duffy MacKay as its first senior VP for dietary supplements. Former CRN executive moves from CV Sciences back into trade group world.

Related Content

Topics

UsernamePublicRestriction

Register

RS151925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel